Pinnacle Bancorp’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$377 Hold
63
﹤0.01% 881
2025
Q4
$452 Hold
63
﹤0.01% 867
2025
Q3
$673 Hold
63
﹤0.01% 901
2025
Q2
$610 Hold
63
﹤0.01% 902
2025
Q1
$938 Hold
63
﹤0.01% 885
2024
Q4
$940 Sell
63
-171
-73% -$2.79K ﹤0.01% 873
2024
Q3
$4.48K Sell
234
-10
-4% -$207 ﹤0.01% 796
2024
Q2
$5.05K Hold
244
﹤0.01% 754
2024
Q1
$4.59K Buy
244
+86
+54% +$1.48K ﹤0.01% 742
2023
Q4
$2.28K Hold
158
﹤0.01% 770
2023
Q3
$2.74K Hold
158
﹤0.01% 741
2023
Q2
$3.29K Hold
158
﹤0.01% 719
2023
Q1
$3.72K Hold
158
﹤0.01% 733
2022
Q4
$4K Sell
158
-50
-24% -$1.28K ﹤0.01% 676
2022
Q3
$5K Hold
208
﹤0.01% 641
2022
Q2
$7K Hold
208
﹤0.01% 622
2022
Q1
$7K Buy
208
+109
+110% +$3.73K ﹤0.01% 638
2021
Q4
$3K Hold
99
﹤0.01% 686
2021
Q3
$3K Buy
+99
New +$3.17K ﹤0.01% 686

Other funds holding OGN

Pinnacle Bancorp's OGN Position: Q1 2026 in Review

Pinnacle Bancorp held its Organon & Co (OGN) position steady in Q1 2026 at 63 shares worth $377. The position accounts for ﹤0.01% of the portfolio, ranked #881.

Pinnacle Bancorp first reported a position in OGN in Q3 2021 and has held it in 19 quarters since. The position peaked at $7K in Q2 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Pinnacle Bancorp held 63 shares of Organon & Co worth $377 as of Q1 2026.
  • Pinnacle Bancorp left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Pinnacle Bancorp's portfolio in Q1 2026, its #881 holding.
  • Pinnacle Bancorp first reported a position in Organon & Co in Q3 2021 and has held it in 19 quarters since.
  • Pinnacle Bancorp's Organon & Co position peaked at $7K in Q2 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Pinnacle Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.